ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 116 filers reported holding ANAPTYSBIO INC in Q4 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $170,000 | -37.7% | 10,510 | +34.3% | 0.02% | -42.9% |
Q3 2019 | $273,000 | -87.4% | 7,826 | -79.6% | 0.04% | -76.7% |
Q2 2019 | $2,166,000 | +3.7% | 38,396 | +91.3% | 0.15% | +12.8% |
Q1 2018 | $2,089,000 | -41.6% | 20,076 | -43.4% | 0.13% | -30.7% |
Q4 2017 | $3,575,000 | -15.7% | 35,500 | -70.8% | 0.19% | -15.4% |
Q3 2017 | $4,242,000 | +139.3% | 121,400 | +63.8% | 0.23% | +108.3% |
Q2 2017 | $1,773,000 | +84.3% | 74,100 | +113.5% | 0.11% | +78.7% |
Q1 2017 | $962,000 | – | 34,700 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $81,462,731 | 11.84% |
EcoR1 Capital, LLC | 7,521,024 | $233,076,534 | 7.09% |
5AM Venture Management, LLC | 357,733 | $11,086,146 | 2.98% |
Boxer Capital, LLC | 1,300,000 | $40,287,000 | 2.12% |
Frazier Life Sciences Management, L.P. | 899,700 | $27,881,703 | 1.73% |
Palo Alto Investors LP | 431,024 | $13,357,434 | 1.14% |
Logos Global Management LP | 250,000 | $7,747,500 | 0.91% |
BRAIDWELL LP | 726,122 | $22,502,521 | 0.75% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,161,826 | $36,004,988 | 0.74% |
Rock Springs Capital Management LP | 576,600 | $17,868,834 | 0.43% |